Search

everythinglearnresearchcommunity

for

Search:↓

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Personalized treatments for hair loss are becoming more effective by using genetic information.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

More research is needed to understand how testosterone is maintained in adult males.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Finasteride may improve prostate cancer treatment outcomes.